FDA slaps clinical hold on Seattle Genetics after four patients die in cancer drug trial – STAT
STAT |
FDA slaps clinical hold on Seattle Genetics after four patients die in cancer drug trial
STAT Four patients have died of liver toxicity while being treated with an experimental cancer drug from Seattle Genetics — leading the US Food and Drug Administration to place a handful of the company's early stage clinical trials involving the treatment … |
